Posted on 03/19/2023 2:22:24 PM PDT by Roman_War_Criminal
Story at a glance:
The antiviral drug remdesivir, brand name Veklury, is approved for use against COVID-19 despite research showing it lacks effectiveness and can cause high rates of organ failure.
John Beaudoin is calling for a criminal investigation into remdesivir, citing data that it may have killed 100,000 people in the U.S.
Beaudoin received all the death certificates in Massachusetts from 2015 to 2022, finding 1,840 excess deaths from acute renal failure from Jan. 1, 2021, to Nov. 30, 2022, which he believes may be due to remdesivir. A study published in The Lancet found “no clinical benefit” from the use of remdesivir in hospitalized patients.
The U.S. government pays hospitals a 20% upcharge on the entire hospital bill when remdesivir is used.
The U.S. Food and Drug Administration (FDA) authorized the experimental antiviral drug remdesivir, brand name Veklury, for emergency use against COVID-19 in May 2020.
By October 2020, it had received full approval. It remains a primary treatment for COVID-19 in hospitals, despite research showing it lacks effectiveness and can cause high rates of organ failure.
(Excerpt) Read more at childrenshealthdefense.org ...
>> The U.S. government pays hospitals a 20% upcharge on the entire hospital bill when remdesivir is used
graft
The medical community is an opportunistic cult
Mrs. OiB got a six-dose series of remdesivir starting on Sept 29, 2021. She died a couple of hours before Oct 1. I suppose the doctors gave her what they thought was best for her.
One of our young relatives went down the exact same path a few days later.
Mercifully, neither of them has to worry about getting diseases related to old age. At least there’s that, I guess.
I’m so sorry for your loss. The same thing happened with my brother. Late August 2021. It still stings knowing what they did to him, and especially how they kept all of us from him. I am bitter about that part.
Stay home until you can’t breathe (pneumonia), go to the emergency room, get put on a ventilator, get two series of Remdesivir (2 5 day series), and then just die (85% death rate). Hospital gets a load of cash and you get the body.
If you feel right about it, then you should tell your story to Mercola, Beaudoin or significant others... in honor of your family's victims.
I am so sorry.
Pure evil what they (knowingly, imo) did, to so many.
Oscar, sorry about your 2 losses, and prayers up for you and your lost loved ones.
I read that a hospital prescribing remdesivir gets a +20% bump on the entire cost of the hospital stay.
What was Trump given in Walter Reed, I though it was remdesiver??
My condolences to you!
I am so sorry this happened.
WHO recommends against the use of remdesivir in COVID-19 patients
20 November 2020
العربية
中文
Français
Русский
Español
WHO has updated its recommendation on remdesivir for the treatment of COVID-19.
On 22 April 2022, following publication of new data from a clinical trial looking at the outcome of admission to hospital, WHO now suggests the use of remdesivir in mild or moderate COVID-19 patients who are at high risk of hospitalization.
Latest information on COVID-19 therapeutics.
WHO has issued a conditional recommendation against the use of remdesivir in hospitalized patients, regardless of disease severity, as there is currently no evidence that remdesivir improves survival and other outcomes in these patients.
This recommendation, released on 20 November, is part of a living guideline on clinical care for COVID-19. It was developed by an international guideline development group, which includes 28 clinical care experts, 4 patient-partners and one ethicist.
The guidelines were developed in collaboration with the non-profit Magic Evidence Ecosystem Foundation (MAGIC), which provided methodologic support. The guidelines are an innovation, matching scientific standards with the speed required to respond to an ongoing pandemic.
Work on this began on 15 October when the WHO Solidarity Trial published its interim results. Data reviewed by the panel included results from this trial, as well as 3 other randomized controlled trials. In all, data from over 7000 patients across the 4 trials were considered.
The evidence suggested no important effect on mortality, need for mechanical ventilation, time to clinical improvement, and other patient-important outcomes.
The guideline development group recognized that more research is needed, especially to provide higher certainty of evidence for specific groups of patients. They supported continued enrollment in trials evaluating remdesivir.
Updated 20 November 2020
* A conditional recommendation is issued when the evidence around the benefits and risks of an intervention are less certain. In this case, there is a conditional recommendation against the use of remdesivir.
This means that there isn’t enough evidence to support its use.
Say her name. Marry oberry. RIP mom. They killed you. No fluids, nutrients just remdesivir. They wouldn’t let me in to protect you. I will take this to my grave. The guilt.
Sad, but a very accurate and succinct description of what happened.
I’m so sorry.
I’m so sorry.
I’m so sorry.
I’m so sorry.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.